| Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and … C Liu, A Bayer, SE Cosgrove, RS Daum, SK Fridkin, RJ Gorwitz, ... Clinical infectious diseases 52 (3), e18-e55, 2011 | 3345 | 2011 |
| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and … M Rybak, B Lomaestro, JC Rotschafer, R Moellering Jr, W Craig, ... American Journal of Health-System Pharmacy 66 (1), 82-98, 2009 | 1520 | 2009 |
| Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart … LM Baddour, WR Wilson, AS Bayer, VG Fowler Jr, IM Tleyjeh, MJ Rybak, ... Circulation 132 (15), 1435-1486, 2015 | 959 | 2015 |
| Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists … MJ Rybak, BM Lomaestro, JC Rotscahfer, RC Moellering Jr, WA Craig, ... Clinical infectious diseases 49 (3), 325-327, 2009 | 710 | 2009 |
| Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia TP Lodise, PS McKinnon, L Swiderski, MJ Rybak Clinical infectious diseases 36 (11), 1418-1423, 2003 | 627 | 2003 |
| The pharmacokinetic and pharmacodynamic properties of vancomycin MJ Rybak Clinical Infectious Diseases 42 (Supplement_1), S35-S39, 2006 | 577 | 2006 |
| Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity MJ Rybak, BJ Abate, SL Kang, MJ Ruffing, SA Lerner, GL Drusano Antimicrobial agents and chemotherapy 43 (7), 1549-1555, 1999 | 424 | 1999 |
| Nephrotoxicity of vancomycin, alone and with an aminoglycoside MJ Rybak, LM Albrecht, SC Boike, PH Chandrasekar Journal of Antimicrobial Chemotherapy 25 (4), 679-687, 1990 | 411 | 1990 |
| Antimicrobial stewardship N Fishman American journal of infection control 34 (5), S55-S63, 2006 | 410 | 2006 |
| Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines … R Kullar, SL Davis, DP Levine, MJ Rybak Clinical Infectious Diseases 52 (8), 975-981, 2011 | 390 | 2011 |
| In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and-resistant … MJ Rybak, E Hershberger, T Moldovan, RG Grucz Antimicrobial Agents and Chemotherapy 44 (4), 1062-1066, 2000 | 383 | 2000 |
| Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro … KL LaPlante, MJ Rybak Antimicrobial agents and chemotherapy 48 (12), 4665-4672, 2004 | 299 | 2004 |
| Therapeutic Monitoring of Vancomycin in Adults: Summary of Consensus Recommendations from the American Society of Health‐System Pharmacists, the Infectious Diseases Society of … MJ Rybak, BM Lomaestro, JC Rotschafer, RC Moellering Jr, WA Craig, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (11 …, 2009 | 231 | 2009 |
| The importance of bactericidal drugs: future directions in infectious disease RW Finberg, RC Moellering, FP Tally, WA Craig, GA Pankey, EP Dellinger, ... Clinical infectious diseases 39 (9), 1314-1320, 2004 | 221 | 2004 |
| Bactericidal Activities of Two Daptomycin Regimens against Clinical Strains of Glycopeptide Intermediate-ResistantStaphylococcus aureus, Vancomycin-ResistantEnterococcus … RL Akins, MJ Rybak Antimicrobial agents and chemotherapy 45 (2), 454-459, 2001 | 210 | 2001 |
| on behalf of the American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on … LM Baddour, WR Wilson, AS Bayer, VG Fowler Jr, IM Tleyjeh, MJ Rybak, ... Circulation 132, 00-00, 2015 | 192 | 2015 |
| Pharmacodynamics of cefepime in patients with Gram-negative infections VH Tam, PS McKinnon, RL Akins, MJ Rybak, GL Drusano Journal of Antimicrobial Chemotherapy 50 (3), 425-428, 2002 | 177 | 2002 |
| Comparison of Length of Hospital Stay for Patients with Known or Suspected Methicillin‐Resistant Staphylococcus Species Infections Treated with Linezolid or … Z Li, RJ Willke, LA Pinto, BE Rittenhouse, MJ Rybak, AM Pleil, CW Crouch, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (3 …, 2001 | 176 | 2001 |
| Community‐Associated Methicillin‐Resistant Staphylococcus aureus: A Review MJ Rybak, KL LaPlante Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (1 …, 2005 | 174 | 2005 |
| Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against … MJ Rybak, DM Cappelletty, T Moldovan, JR Aeschlimann, GW Kaatz Antimicrobial agents and chemotherapy 42 (3), 721-724, 1998 | 172 | 1998 |
